Most development plans are built one function at a time. Nonclinical designs the tox program. CMC builds a process to supply it. Regulatory writes a strategy around what’s been done. Quality audits the result. Each step is sound. The plan, taken as a whole, often isn’t.
Playbook
The Integrated Development Roadmap Playbook

Related Resources
All Resources

post
The FDA NDA Review Timeline Explained: A Step-by-Step Breakdown
Read More

post
Project Orbis: Accelerating Global Access to Innovative Cancer Therapies
Read More

post
The Importance of Quality in Drug Development with Insights from the FDA Fiscal Year 2023 Report on the State of Pharmaceutical Quality
Read More

post
Why are Biologics Drugs Different
Read More
Let's move from science to success.
Let’s Talk